Current status:
Cancelled Post Market
Current status date:
1996-12-12
Product name:
REVERIN 275MG
DIN:
00012521
Electronic product monograph is not available
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intrapleural
,
Intra-Articular
,
Intraperitoneal
,
Intravenous
,
Intrathecal
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
J01AA09 ROLITETRACYCLINE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ROLITETRACYCLINE
|
275 MG / VIAL
|